0 likes | 0 Vues
The global Epigenetics Diagnostics Market is experiencing rapid growth, driven by increased awareness of personalized medicine and the role of epigenetic alterations in complex diseases. The market is projected to expand significantly, rising from a value of USD 2.9 billion in 2024 to USD 15.8 billion by 2037, reflecting a Compound Annual Growth Rate (CAGR) of 19.9%. This growth trajectory underscores the transformative potential of epigenetic tools in diagnostics, offering non-invasive, early-detection solutions for diseases that were previously difficult to identify at an early stage.<br>Epigen
E N D